Aurora Cannabis Sets Q1 2026 Investor Call for Aug 8

Ticker: ACB · Form: 6-K · Filed: 2025-07-24T00:00:00.000Z

Sentiment: neutral

Topics: earnings-call, investor-relations, cannabis

Related Tickers: ACB

TL;DR

ACB hosting Q1 2026 earnings call Aug 8th - tune in for the numbers.

AI Summary

Aurora Cannabis Inc. announced on July 23, 2025, that it will host its first quarter 2026 investor conference call on August 8, 2025. The call will discuss the company's financial and operational results for the period ending June 30, 2025. Miguel Martin, CEO, will present the findings.

Why It Matters

This call provides investors with crucial insights into Aurora Cannabis's recent financial performance and strategic direction, impacting investment decisions.

Risk Assessment

Risk Level: medium — The cannabis industry faces regulatory uncertainty and market volatility, which can impact Aurora Cannabis's financial results and stock performance.

Key Players & Entities

FAQ

When will Aurora Cannabis host its first quarter 2026 investor conference call?

Aurora Cannabis will host its first quarter 2026 investor conference call on August 8, 2025.

What period will the Q1 2026 investor call cover?

The call will discuss the company's financial and operational results for the first quarter of 2026, ending June 30, 2025.

Who will present during the investor conference call?

Miguel Martin, Chief Executive Officer of Aurora Cannabis Inc., will present during the investor conference call.

What is the ticker symbol for Aurora Cannabis Inc. on NASDAQ and TSX?

The ticker symbol for Aurora Cannabis Inc. on both NASDAQ and TSX is ACB.

What form is this SEC filing?

This SEC filing is a Form 6-K, a Report of Foreign Private Issuer.

From the Filing

0001279569-25-000785.txt : 20250724 0001279569-25-000785.hdr.sgml : 20250724 20250724131756 ACCESSION NUMBER: 0001279569-25-000785 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20250723 FILED AS OF DATE: 20250724 DATE AS OF CHANGE: 20250724 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AURORA CANNABIS INC CENTRAL INDEX KEY: 0001683541 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38691 FILM NUMBER: 251145843 BUSINESS ADDRESS: STREET 1: 2207 90B STREET SW CITY: EDMONTON STATE: A0 ZIP: T6X 1V8 BUSINESS PHONE: 604-362-5207 MAIL ADDRESS: STREET 1: 409 GRANVILLE STREET STREET 2: SUITE 1700 CITY: VANCOUVER STATE: A1 ZIP: V6C 1T2 6-K 1 aurora_6k.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2025 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 2207 90B St. SW Edmonton, Alberta T6X 1V8 Canada (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F Form 20-F ☐ Form 40-F ☒ SUBMITTED HEREWITH Exhibits Description 99.1 News release dated July 23, 2025 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. AURORA CANNABIS INC. /s/ Miguel Martin Miguel Martin Chief Executive Officer Date: July 23, 2025 EX-99.1 2 ex991.htm NEWS RELEASE DATED JULY 23, 2025 Exhibit 99.1 Aurora Cannabis to Host First Quarter 2026 Investor Conference Call NASDAQ | TSX: ACB EDMONTON, AB, July 23, 2025 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian based leading global medical cannabis company, announced today that it has scheduled a conference call to discuss the results for its first quarter 2026 on Wednesday, August 6, 2025 at 8:00 a.m. Eastern Time | 6:00 a.m. Mountain Time. The Company will report its financial results for the first quarter 2026 before the opening of markets that same day. Conference Call Details DATE: Wednesday, August 6, 2025 TIME: 8:00 a.m. Eastern Time 6:00 a.m. Mountain Time WEBCAST: Click Here Miguel Martin, Executive Chairman and Chief Executive Officer, and Simona King, Chief Financial Officer, will host the conference call and question and answer period. This weblink has also been posted to the Company's "Investor Info" link at https://www.auroramj.com/investors/ under "Events". About Aurora Cannabis Aurora is opening the world to cannabis, serving both the medical and consumer markets across Canada, Europe, Australia and New Zealand. Headquartered in Edmonton, Alberta, Aurora is a pioneer in global cannabis, dedicated to helping people improve their lives. The Company's adult- use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, IndiMed and CraftPlant. Aurora also has a controlling interest in Bevo Farms Ltd., North America's leading supplier of propagated agricultural plants. Driven by science and innovation, and with a focus on high-quality cannabis products, Aurora's brands continue to break through as industry leaders in the medical, wellness and adult recreational markets wherever they are launched. Learn more at www.auroramj.com and follow us on X and LinkedIn. Aurora's common shares trade on the NASDAQ and TSX under the symbol "ACB". Fo

View on Read The Filing